Total Payments
$2,413
2024 Payments
$596.94
Companies
23
Transactions
79
Medicare Patients
409
Medicare Billing
$62,224
Payment Breakdown by Category
Food & Beverage$1,451 (60.1%)
Education$481.99 (20.0%)
Other$320.12 (13.3%)
Travel$159.91 (6.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,451 | 65 | 60.1% |
| Education | $481.99 | 7 | 20.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $228.66 | 1 | 9.5% |
| Travel and Lodging | $159.91 | 5 | 6.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $91.46 | 1 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $372.47 | 5 | $0 (2024) |
| Astellas Pharma US Inc | $326.06 | 6 | $0 (2024) |
| Celgene Corporation | $199.66 | 8 | $0 (2024) |
| Pharmacyclics LLC, an AbbVie Company | $163.81 | 6 | $0 (2022) |
| Genentech USA, Inc. | $160.54 | 6 | $0 (2024) |
| TAIHO ONCOLOGY, INC. | $125.92 | 3 | $0 (2023) |
| Janssen Biotech, Inc. | $118.14 | 5 | $0 (2024) |
| Incyte Corporation | $82.74 | 4 | $0 (2024) |
| Daiichi Sankyo Inc. | $80.88 | 4 | $0 (2024) |
| ABBVIE INC. | $80.70 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $596.94 | 22 | Helsinn Therapeutics (U.S.), Inc. ($77.51) |
| 2023 | $1,088 | 30 | AstraZeneca Pharmaceuticals LP ($354.11) |
| 2022 | $216.34 | 11 | ABBVIE INC. ($80.70) |
| 2021 | $511.41 | 16 | Pharmacyclics LLC, An AbbVie Company ($137.88) |
All Payment Transactions
79 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Helsinn Therapeutics (U.S.), Inc. | VALCHLOR (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $20.28 | General |
| Category: Hematology | ||||||
| 10/29/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $36.20 | General |
| Category: Oncology | ||||||
| 09/06/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Education | In-kind items and services | $23.50 | General |
| Category: Monoclonal Antibody | ||||||
| 08/21/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $34.57 | General |
| Category: ONCOLOGY | ||||||
| 08/16/2024 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $29.91 | General |
| Category: BioOncology | ||||||
| 08/14/2024 | Helsinn Therapeutics (U.S.), Inc. | VALCHLOR (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: ONCOLOGY | ||||||
| 06/07/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Oncology | ||||||
| 05/23/2024 | Secura Bio, Inc. | COPIKTRA (Drug) | Food and Beverage | In-kind items and services | $70.00 | General |
| Category: ORAL ONCOLOGIC | ||||||
| 05/17/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $70.00 | General |
| 05/15/2024 | Helsinn Therapeutics (U.S.), Inc. | VALCHLOR (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: ONCOLOGY | ||||||
| 05/06/2024 | Incyte Corporation | MONJUVI (Drug), PEMAZYRE | Food and Beverage | Cash or cash equivalent | $20.45 | General |
| Category: Oncology | ||||||
| 04/24/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: ONCOLOGY | ||||||
| 03/27/2024 | Helsinn Therapeutics (U.S.), Inc. | VALCHLOR (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: ONCOLOGY | ||||||
| 03/21/2024 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $28.17 | General |
| Category: BioOncology | ||||||
| 03/13/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug), DIFICID | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/14/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: Rare Disease | ||||||
| 01/24/2024 | JAZZ PHARMACEUTICALS INC. | DEFITELIO (Drug) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 01/24/2024 | Helsinn Therapeutics (U.S.), Inc. | VALCHLOR (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: ONCOLOGY | ||||||
| 01/22/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $29.88 | General |
| Category: Hematology | ||||||
| 01/12/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Oncology | ||||||
| 01/08/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2023 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $30.27 | General |
| Category: BioOncology | ||||||
| 11/15/2023 | Daiichi Sankyo Inc. | — | Food and Beverage | In-kind items and services | $23.47 | General |
| 11/15/2023 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 150 | 315 | $102,464 | $26,910 |
| 2022 | 2 | 104 | 243 | $63,696 | $17,034 |
| 2021 | 2 | 95 | 205 | $50,344 | $14,187 |
| 2020 | 2 | 60 | 88 | $18,434 | $4,094 |
Total Patients
409
Total Services
851
Medicare Billing
$62,224
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 71 | 176 | $66,880 | $17,935 | 26.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 79 | 139 | $35,584 | $8,975 | 25.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 92 | 231 | $59,136 | $15,758 | 26.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 12 | 12 | $4,560 | $1,275 | 28.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 72 | 181 | $46,336 | $13,148 | 28.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 23 | 24 | $4,008 | $1,039 | 25.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 26 | 42 | $10,752 | $2,390 | 22.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 34 | 46 | $7,682 | $1,704 | 22.2% |
About Lauren Clermont, NP
Lauren Clermont, NP is a Family healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/31/2013. The National Provider Identifier (NPI) number assigned to this provider is 1821419342.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lauren Clermont, NP has received a total of $2,413 in payments from pharmaceutical and medical device companies, with $596.94 received in 2024. These payments were reported across 79 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,451).
As a Medicare-enrolled provider, Clermont has provided services to 409 Medicare beneficiaries, totaling 851 services with total Medicare billing of $62,224. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Nurse Practitioner
- Location Seattle, WA
- Active Since 12/31/2013
- Last Updated 02/04/2026
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1821419342
Products in Payments
- IMBRUVICA (Drug) $245.02
- Venclexta (Biological) $160.54
- REBLOZYL (Biological) $152.77
- BRUKINSA (Drug) $78.30
- VALCHLOR (Drug) $77.51
- ADCETRIS (Biological) $77.34
- TAZVERIK (Drug) $73.99
- COPIKTRA (Drug) $70.00
- PROMACTA (Drug) $68.34
- VENCLEXTA (Drug) $60.81
- Xospata (Drug) $60.06
- MONJUVI (Drug) $57.81
- Nplate (Biological) $42.98
- Vanflyta (Drug) $41.83
- PREVYMIS (Drug) $37.15
- DARZALEX (Biological) $36.93
- LIBTAYO (Biological) $34.57
- ULTOMIRIS (Biological) $27.35
- DEFITELIO (Drug) $26.80
- PEMAZYRE (Drug) $24.93
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Seattle
Dr. Kevan Petterson, Dnp, Fnp, DNP, FNP
Family — Payments: $55,987
Family $55,987
Dr. Kaitlin Brasier, D.n.p., A.r.n.p., Rn, D.N.P., A.R.N.P., RN
Family — Payments: $27,842
Family $27,842
Ms. Karen Johnson, Arnp, ARNP
Family — Payments: $14,117
Family $14,117
Omeid Heidari, Phd, Msn, Anp-C, PHD, MSN, ANP-C
Family — Payments: $12,629
Family $12,629
Lilly Silva, Rn, Fnp, Msn, RN, FNP, MSN
Family — Payments: $9,101
Family $9,101
Amy Perez, Fnp, FNP
Family — Payments: $8,589
Family $8,589